top of page

Jan 7th

Prednisolone for the Prevention of Paradoxical Tuberculosis-Associated IRIS

Dr Bushra

Jan 14TH

Mortality and Morbidity Meeting

Dr Bushra/Dr Ong/Dr Helmi

NIL SLIDES

Mar 11st

Bangkok HIV Conference Update 2019

Dr. Bushra

Mar 18tH

Isavuconazole versus Caspofungin in the Treatment of Candidemia

and Other Invasive Candida Infections: The ACTIVE Trial

Dr Chandravasheni/Dr Wong PL

APR 1st

Yellow Fever Vaccination

Dr Asma

NIL SLIDE

APR 8th

The ANDROMEDA-SHOCK randomized clinical trial

Dr Thye CK & Dr Ong HC 

APRIL 15th

Antibiotic Treatment Duration for Bacteremia due to Enterobacteriaceae

Dr Dian Nazlee & Dr. Bushra

APRIL 22nd

Management of Febrile Neutropenia in Special Consideration of the Role of Antimicrobial deescalation

Dr Siti Nadia & Dr. Ng RX

May 13th

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

​

MERINO Study

Dr. Helmi

May 28th

Sarawak Rabies Update

Dr Ong HC

Slide Courtesy from Dr Andrew Chang

JUNE 10th

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Dr ONG HC 

July

15th

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Dr. Sazali & Dr. NG RX

July

25th

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia

Dr Priscilla & Dr Bushra

Aug

5th

ECCMID 2019 update

1) Chronic disseminated candidiasis/CDC

2) CNS device infection.

Dr. Helmi

Aug

19th

APACC 2019 Update 

State or ART 

Dr. NG RX

Aug

26 th

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Dr. Sazali

Coming soon 

CAP HCAP Discussion- ED & ID Team

Dr Helmi

COMING SOON
bottom of page